Toggle light / dark theme

Join us on Patreon!
https://www.patreon.com/MichaelLustgartenPhD

Green Tea Discount Link (Ocha & Co)
https://www.ochaandco.com/?ref=conqueraging.

Bristle Discount Link (Oral Microbiome Quantification):
ConquerAging15
https://www.bmq30trk.com/4FL3LK/GTSC3/

TruDiagnostic Discount Link (Epigenetic Testing)

I never thought I’d order live human kidney cells to my address, but that all changed when I found out about biohacker Jo Zayner’s at-home genetic engineering class.

You may know Jo Zayner, a “biohacker” who has been in the vanguard of scientific self-experimentation for years, from their role in Netflix’s 2019 docuseries Unnatural Selection. The series shows Zayner attempting to edit their DNA by injecting themselves with CRISPR, a gene-editing technology. The action inspired a firestorm of criticism.

Zayner is also known for a variety of other bold moves, such as claiming to create a DIY at-home COVID vaccine in 2020 and executing their own fecal microbiome transplant.

CRISPR may be in for a fight thanks to this new, faster, safer, AI-powered zinc-finger gene-editing technique.

A new study has developed what the researchers call the “world’s first” simple, modifiable proteins. Called “zinc fingers,” these special proteins were developed partially through artificial intelligence.

Scientists from the University of Toronto and the NYU Grossman School of Medicine came up with the method, which is expected to speed up the development of gene therapies. This could be a game-changer for how doctors treat DNA mistakes that happen over time. This is partly because our genes change naturally as we age, which makes it inevitable that mistakes will happen. Or, of course, from genetic disorders inherited at birth.

Cancer cells can shrink or super-size themselves to survive drug treatment or other challenges within their environment, researchers have discovered.

Scientists at The Institute of Cancer Research, London, combined biochemical profiling technologies with to reveal how lead to differences in the size of cancer cells—and how these changes could be exploited by new treatments.

The researchers believe smaller cells could be more vulnerable to DNA-damaging agents like chemotherapy combined with targeted drugs, while larger cancer cells might respond better to immunotherapy.

ABOVE: © ISTOCK.COM, DR_MICROBE

Mycoplasma pneumoniae are tiny bacteria typically known to cause lung infections. But now, a group of scientists have turned them into double agents. Genetically engineered Mycoplasma helped break down biofilms of another pathogenic microbe, Pseudomonas aeruginosa, in a mouse model of ventilator-associated pneumonia and on tube samples taken from human patients, the team reported January 19 in Nature Biotechnology. It is one of the first times that scientists have used live bacteria to treat a lung disease, and is the first therapeutic use of Mycoplasma.

“This approach is really powerful,” says Dave Hava, a microbiologist who wasn’t involved in the research, but who works at a company called Synlogic that develops live bacteria therapeutics for gut issues. “It offers the chance to target diseases and mechanisms that you can’t do with conventional therapies.”

China building Bio Weapon that can target people based on race. China has been amassing a disturbing amount of genetic data from the rest of the world, and it’s been doing it for something nightmarish.

◘ Rob Reid — Why the Future is the Good Kind of Scary.

510: Rob Reid | Why the Future is a Good Kind of Scary


◘ Subscribe to Jordan Harbinger Podcast.

Subscribe to the Podcast

◘ Support me on Patreon for early release, and much more! http://www.patreon.com/laowhy86
◘ Donate and support this channel through Paypal http://paypal.me/cmilkrun.

Crypto support.